Nanomedicine News

RSS

Researchers Discover Ormosil Nanoparticles as Potential Drug Delivery Vehicle to Brain

Shermali Gunawardana, University of Buffalo researcher, discovered that ORMOSIL nanoparticles when injected into the brain of insects, which even after being exposed for a long time, did not affect the flies and cells in any way.

11 Jan 2012

Nanomedicine Company, Blend Therapeutics Announces its Founding Mission

Blend Therapeutics, a biotechnology firm founded by Dr. Omid Farokhzad, Director of Laboratory of Nanomedicine and Biomaterials at Harvard Medical School, and Dr. Stephen Lippard and Dr. Robert Langer, Professors from the Massachusetts Institute of Technology, has declared its founding mission.

10 Jan 2012

Alnylam Submits CTA for Lipid Nanoparticle-Based RNAi TTR, ALN-TTR02

Alnylam Pharmaceuticals, a company specializing in RNAi therapeutics, has announced the submission of a clinical trial application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to start a Phase I clinical study of its RNAi therapeutic targeting transthyretin (TTR) called ALN-TTR02 for treating TTR-mediated amyloidosis (ATTR).

10 Jan 2012

MonoSol Rx and Nanomedicine Firm Midatech Form Joint Venture Company

Midatech, a nanomedicine company developing MidaForm nanoparticle excipients, and MonoSol Rx, a company developing PharmFilm drug delivery technology, have formed a joint venture company, MidaSol Therapeutics.

9 Jan 2012

Tetragenetics Reports Preclinical Study Results of Nanoparticle-Based Influenza Vaccine

Tetragenetics, a developer of recombinant vaccines, has presented preclinical study findings of an influenza vaccine candidate based on nanoparticles.

7 Jan 2012

Alnylam Reports Positive Results for Nanotech-Enabled RNAi Therapeutic Targeting PCSK9

Tekmira Pharmaceuticals, a company specializing in novel RNA interference (RNAi) therapeutics, has announced that Alnylam Pharmaceuticals has reported encouraging initial results from its continuing human clinical study of a target-specific RNAi therapeutic for PCSK9 called ALN-PCS for treatment of dangerous hypercholesterolemia using the lipid nanoparticle technology of Tekmira.

7 Jan 2012

Georgia Tech Researchers Use Malvern Zetasizer Nano to Predict Protein Aggregation

Researchers at the Georgia Institute of Technology School of Chemical & Biomolecular Engineering (Georgia, US) are using the simple-to-use technique of dynamic light scattering (DLS) measurements to predict otherwise difficult-to-measure aggregation behaviors in proteins.

From Malvern Panalytical 5 Jan 2012

Researcher to Explore Use of Nanotechnology in Developing Gene Therapies

Laura Conforti, who serves as an Associate Professor at the University of Cincinnati, has been awarded two grants to study the defects in the immune system function, paving the way for developing gene therapies to prevent the growth of tumor and for systemic lupus erythematosus.

27 Dec 2011

Manhattan Scientifics Leads with Magnetic Nano-Particle-Based Early Cancer Detection Technology

An article titled, ‘The race is on for a better mammogram’ written by Sierra Jiminez in the online Fortune Magazine on 19 December 2011 has described the nanotechnology-based early breast cancer detection technology of Edward R. Flynn, who serves at Manhattan Scientifics.

From Manhattan Scientifics Inc. 23 Dec 2011

Novel Electronic Quantum Dots Probe Paves Way to Rapidly Test Drug Efficiency

A research team led by Swadeshmukul Santra, an Associate Professor at the University of Central Florida, has developed an electronic quantum dots probe that paves the way for testing the efficiency of new pharmaceuticals rapidly.

21 Dec 2011